Last update Jan. 12, 2022
Very Low Risk
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Desloratadine is also known as
Desloratadine in other languages or writings:
Desloratadine belongs to this group or family:
|Oral Bioavail.||Alta - Hig||%|
|Protein Binding||82 - 87||%|
|T½||20 - 30||hours|
Write us at firstname.lastname@example.org
e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Second generation anti-histaminic drug with low sedative effect. Desloratadine es the active metabolite of loratadine. Its characteristics might be extrapolated to those of loratadine. (So 2010)
Loratadine is excreted in non-significant amount into breast milk (Hilbert 1988). No side effects were observed in breastfed infants of treated mothers. (Merlob 2002)
Various medical societies and expert consensus consider the use of loratadine safe during breastfeeding (So 2010, National Asthma Ed. 2004, Solhaug 2004, Ghaeli 1993). The British Society of Immunology and Allergy rates loratadine compatible with breastfeeding. (Powell 2007)
American Academy of Pediatrics: loratadine is a medication usually compatible with breastfeeding. (AAP 2001)
See below the information of this related product: